Kathleen Maguire-Zeiss

Dr. Kathleen Maguire-Zeiss

Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Neurobiology of Aging
Verified
Journal Article
Closed access
XSXiaomin Su
Xiaomin Su
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss
RGRita Giuliano
Rita Giuliano
LPLanda Prifti
Landa Prifti
KVKarthik Venkatesh
Karthik Venkatesh
HFHoward J. Federoff
Howard J. Federoff

6 December 2012
Verified
Book Chapter
Closed access
PDF file
TMTimothy R. Mhyre
Timothy R. Mhyre
JBJames T. Boyd
James T. Boyd
RHRobert W. Hamill
Robert W. Hamill
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss

12 May 2015 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SDStefano G. Daniele
Stefano G. Daniele
DBDawn Béraud
Dawn Béraud
CDConnor Davenport
Connor Davenport
KCKui Cheng
Kui Cheng
HYHang Yin
Hang Yin
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss
Synucleinopathies, such as Parkinson’s disease and diffuse Lewy body disease, are progressive neurodegenerative disorders characterized by selective neuronal death, abnormal accumulation of misfolded α-synuclein, and sustained microglial activation. In addition to inducing neuronal toxicity, higher-ordered oligomeric α-synuclein causes proinflammatory responses in the brain parenchyma by triggering microglial activation, which may exacerbate pathogenic processes by establishing a chronic neuroinflammatory milieu. We found that higher-ordered oligomeric α-synuclein induced a proinflammatory microglial phenotype by directly engaging the heterodimer TLR1/2 (Toll-like receptor 1 and 2) at the cell membrane, leading to the nuclear translocation of NF-κB (nuclear factor κB) and the increased production of the proinflammatory cytokines TNF-α (tumor necrosis factor–α) and IL-1β (interleukin-1β) in a MyD88-dependent manner. Blocking signaling through the TLR1/2 heterodimer with the small-molecule inhibitor CU-CPT22 reduced the nuclear translocation of NF-κB and secretion of TNF-α from cultured primary mouse microglia. Candesartan cilexetil, a drug approved for treating hypertension and that inhibits the expression of TLR2, reversed the activated proinflammatory phenotype of primary microglia exposed to oligomeric α-synuclein, supporting the possibility of repurposing this drug for synucleinopathies.

10 October 2012 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Open access
PDF file
DBDawn Béraud
Dawn Béraud
HHHannah A. Hathaway
Hannah A. Hathaway
JTJordan Trecki
Jordan Trecki
SCSergey Chasovskikh
Sergey Chasovskikh
DJDelinda A. Johnson
Delinda A. Johnson
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder typified by tremor, rigidity, akinesia and postural instability due in part to the loss of dopamine within the nigrostriatal system. The pathologic features of this disorder include the loss of substantia nigra dopamine neurons and attendant striatal terminals, the presence of large protein-rich neuronal inclusions containing fibrillar α-synuclein and increased numbers of activated microglia. Evidence suggests that both misfolded α-synuclein and oxidative stress play an important role in the pathogenesis of sporadic PD. Here we review evidence that α-synuclein activates glia inducing inflammation and that Nrf2-directed phase-II antioxidant enzymes play an important role in PD. We also provide new evidence that the expression of antioxidant enzymes regulated in part by Nrf2 is increased in a mouse model of α-synuclein overexpression. We show that misfolded α-synuclein directly activates microglia inducing the production and release of the proinflammatory cytokine, TNF-α, and increasing antioxidant enzyme expression. Importantly, we demonstrate that the precise structure of α-synuclein is important for induction of this proinflammatory pathway. This complex α-synuclein-directed glial response highlights the importance of protein misfolding, oxidative stress and inflammation in PD and represents a potential locus for the development of novel therapeutics focused on induction of the Nrf2-directed antioxidant pathway and inhibition of protein misfolding.

1 January 2011 in Frontiers in Neuroscience
Verified
Journal Article
Open access
DBDawn Béraud
Dawn Béraud
MTMargaret Twomey
Margaret Twomey
BBBenjamin Bloom
Benjamin Bloom
AMAndrew Mittereder
Andrew Mittereder
VTVy Ton
Vy Ton
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss
Parkinson’s disease, an age-related neurodegenerative disorder, is characterized by the loss of dopamine neurons in the substantia nigra, the accumulation of α-synuclein in Lewy bodies and neurites, and neuroinflammation. While the exact etiology of sporadic Parkinson’s disease remains elusive, a growing body of evidence suggests that misfolded α-synuclein promotes inflammation and oxidative stress resulting in neurodegeneration. α-Synuclein has been directly linked to microglial activation in vitro and increased numbers of activated microglia have been reported in an α-synuclein overexpressing mouse model prior to neuronal loss. However, the mechanism by which α-synuclein incites microglial activation has not been fully described. Microglial activation is governed in part, by pattern recognition receptors that detect foreign material and additionally recognize changes in homeostatic cellular conditions. Upon proinflammatory pathway initiation, activated microglia contribute to oxidative stress through release of cytokines, nitric oxide, and other reactive oxygen species, which may adversely impact adjacent neurons. Here we show that microglia are directly activated by α-synuclein in a classical activation pathway that includes alterations in the expression of toll-like receptors. These data suggest that α-synuclein can act as a danger-associated molecular pattern.

28 April 2009 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
XSXiaomin Su
Xiaomin Su
HFHoward J. Federoff
Howard J. Federoff
Kathleen Maguire-ZeissKathleen Maguire-Zeiss
Kathleen Maguire-Zeiss